Image For Activity Cover
Heart Meets Kidney
General Meeting Information

Cardiorenal syndrome (CRS) represents a systemic process whereby dysfunction in the kidney or heart leads to dysfunction in the other organ. In the setting of acute decompensated heart failure, type 1 CRS, is quite common and the management is predicated on effective decongestion through diuretics and other decongestive strategies. Recently, there has been a growing interest in non-medication and device therapy to facilitate decongestion as alternative medications such as vasopressin antagonists, inotropes and other vasoactive medications have failed to show clinical efficacy. This multi-disciplinary session will cover the approach to managing patients with acute heart failure and type 1 CRS. Discussion will include novel biomarkers, drugs, devices and clinical management strategies to reverse CRS and adequately decongest acute heart failure patients.

Learning Objectives
  • Describe the pathophysiology and clinical significance of cardiorenal syndrome in acute heart failure.
  • Identify strategies to optimize diuretic efficiency and delivery.
  • Discuss drug and device-based, non-diuretic management strategies for diuretic resistance heart failure patients.
Availability: On-Demand
Expires on Sep 01, 2022
Cost : Member: $29.00
Non-Member: $45.00
Credit Offered:
1 CME Credit
1 MOC Point
Powered by Oasis.